Let's Find Opportunities Overseas

Tag: DeepValue

Magnachip MX chip at a crossroads between its troubled past and a silicon carbide turnaround backed by CEO buying and Navitas.

🔌 Magnachip ( MX): Deep-Value Bargain or Ultimate Value Trap? CEO Buys $318K as Navitas Bets $5M ⚡

Magnachip has spent 15 years destroying shareholder value. Now its new CEO is buying 100,000 shares, Navitas is investing $5 million, and a silicon-carbide pivot is taking shape. Deep-value bargain—or another chapter in the value trap?

Read entire article

Tags: buy or sell MX, CarpeDiem, CEOBuysShares, Chae Lee, ContrarianInvestment, deep value investing, DeepValue, EV charging, featured-insiders, featured-overseas, FUNanc1al, FunStock Index, FunStock Method, hub-insiders, hub-overseas, insider buying, insider purchases, InsiderBuying, institutional ownership, Magnachip, Magnachip Semiconductor, MX, Navitas, Navitas Semiconductor, NVTS, power semiconductors, risks buying MX, semiconductor industry, semiconductor investing, semiconductor stocks, Semiconductors, SiC, silicon carbide, small cap stocks, Turnaround, turnaround stocks, value stocks, why buy MX
Teva Pharmaceuticals stock price on a monitor, with prescription pills and an Israeli flag in the background—symbolizing resurgence and hedge fund interest in TEVA stock.

Teva Pharma: The Funds Believe. Should You?

Hedge fund legend Stanley Druckenmiller just upped his stake in TEVA by 65%—and he’s not alone. With 9 straight quarters of growth, rising biosimilar momentum, and a “Pivot to Growth” strategy in motion, Teva might finally be ready for its rerating. We still like the sandals, but the stock may be worth more than a hike.

Read entire article

Tags: Biosimilars, BiotechStocks, DeepValue, Druckenmiller, Funanc1al, Funanc1al Contrarian Picks, Funanc1al Contrarian Plays, Funanc1al Edge, Funanc1al for Investors, Funanc1al Insider Series, Funanc1al International Investment Series, Funanc1al Investing, Funanc1al Turnaround Plays, Funanc1alEdge, Funanc1alFinance, Funanc1alFun, Funanc1alInsiders, Funanc1alInsiderSeries, Funanc1alInternational, Funanc1alStocks, GenericDrugs, HedgeFundBuys, InsiderBuying, IsraelStocks, PharmaInvesting, TEVA, ValueInvesting